Dr. Rasooly's research aims to understand diagnostic decision making and leverage the electronic health record to support diagnostic excellence. Her current work focuses on recognition of child abuse, evaluating decision making in simulation, and improving diagnostic performance at CHOP.
Dr. Spinner's research focuses on the etiology and expressivity of pediatric developmental disorders. She uses genomic methods to focus on the multisystem disorder Alagille syndrome and biliary atresia, a likely heterogeneous and poorly understood condition. She is also interested in using genomic tools to continue to improve diagnostic rates for constitutional genetic disorders.
Dr. Otero is an attending radiologist in the Division of Body Imaging with research interests in global health, health services research, genitourinary, cardiovascular, lymphatic, and pulmonary imaging.
Dr. Laura Cubit conducts comprehensive developmental and diagnostic evaluations for children from infancy through adolescence, including autism evaluations. She also provides Parent-Child Interaction Therapy for children and their families. Dr. Cubit supervises clinical trainees and research staff.
Dr. Woods-Hill researches diagnostic and treatment decision-making in the critical care setting, with a specific interest on the impact of these decisions on unintended patient harm and medical overuse. She focuses on bacterial bloodstream infections in children in the PICU, and diagnostic stewardship in this context.
Dr. Kurre's laboratory has longstanding expertise in Fanconi Anemia (FA), a genetic condition with prominent hematologic complications. With training in transplantation and hematopoietic stem cell biology, he hopes to improve the understanding of the progressive hematopoietic failure in patients with bone marrow failure and FA, broaden diagnostic approaches, and develop next generation therapies.
Dr. Moser serves in a primarily clinical role at the Center for Autism Research on the Infant Brain Imaging Study, conducting clinical and diagnostic evaluations for infants, toddlers, and school-age children with and without autism spectrum disorder, as well as individuals with Down syndrome.
Dr. Bennett’s research interests include screening for medical and behavioral co-morbidities in individuals with developmental disabilities, with specific interest in improving screening and outcome measures for children with autism spectrum disorder.
Dr. Glessner’s current research focuses on childhood neuropsychiatric and neurodevelopmental disorders along with the genetic architecture associated with them, including single nucleotide polymorphisms, single nucleotide variations, and copy number variations ascertained by genomic technologies.